Skip to main content

Navalign, LLC

SEC CIK
0001820593
Latest filing
Jul 27, 2026

Holdings in Q4 2024

Holdings as of Dec 31, 2024, filed Feb 18, 2025. Long positions only; changes compare share counts with Q3 2024.

Institution overview
Positions
116
−2 vs. Q3 2024
Portfolio value
$340.2M
+$515.9K (+0.2%) vs. Q3 2024
Filed
Feb 18, 2025
SEC
Holdings of Navalign, LLC in Q4 2024
SecurityClassSharesValue% of portfolioShare changeActionHistory
PAYXPaychex IncStock2,289$321.0K0.1%00.0%UnchangedHistory
Goldman Sachs ETF Tr381430230ULTR SHOR BD ETF6,086$305.6K0.1%+2,037+50.3%Added–
VZVerizon Communications IncStock7,621$304.7K0.1%−1,689−18.1%ReducedHistory
Vanguard Ftse Developed Markets ETF921943858ETF6,330$302.7K0.1%−805−11.3%Reduced–
DISWalt Disney CoStock2,594$288.8K0.1%+357+16.0%AddedHistory
LOWLowes Companies IncStock1,154$284.9K0.1%+140+13.8%AddedHistory
iShares Tr46434V860TRS FLT RT BD5,550$280.1K0.1%00.0%Unchanged–
ABTAbbott LaboratoriesStock2,472$279.6K0.1%−70−2.8%ReducedHistory
PFEPfizer IncStock10,088$267.6K0.1%−990−8.9%ReducedHistory
IBMInternational Business Machines CorpStock1,119$246.0K0.1%00.0%UnchangedHistory
PEPPepsiCo IncStock1,557$236.8K0.1%+1,557NewHistory
Invesco QQQ Trust Series I46090E103ETF425$217.1K0.1%00.0%Unchanged–
SYKStryker CorpStock590$212.4K0.1%00.0%UnchangedHistory
Vanguard Scottsdale FDS92206C409SHRT TRM CORP BD2,706$211.1K0.1%+2,706New–
ALLOAllogene Therapeutics, Inc.COM59,865$127.5K<0.1%−15,500−20.6%ReducedHistory
CUECue Biopharma, Inc.COM25,000$27.3K<0.1%+25,000NewHistory

Sold out since Q3 2024 (7)

Positions held at the end of Q3 2024 that are gone from this filing.

Positions of Navalign, LLC sold out since Q3 2024
SecurityClassShares in Q3 2024Value in Q3 2024% of portfolio in Q3 2024History
ELEstee Lauder Companies IncCL A3,982$397.0K0.1%History
SPDR Series Trust78464A656ST STR TIPS ETF14,377$377.8K0.1%–
Vanguard Star FDS921909768VG TL INTL STK F5,102$330.3K0.1%–
XOMExxonMobil Holdings CorpCOM2,005$235.1K0.1%History
LMTLockheed Martin CorpStock398$232.7K0.1%History
Vanguard Morningstar Value ETF922908744ETF1,191$207.9K0.1%–
AZNAstraZeneca PLCSPONSORED ADR2,625$204.5K0.1%History